US OptionsDetailed Quotes

WSFS240816C55000

Watchlist

3.80
+0.40+11.76%

15min DelayClose Jul 25 16:00 ET

3.80High3.80Low

WSFS Financial Stock Discussion

Meticulous Trader

Jul 16 20:06

$WSFS Financial(WSFS.US)$

Moomoo AI

Oct 28, 2023 07:22

WSFS Financial's rapid growth and low payout ratio, which indicate a high reinvestment in the business, make it an attractive investment opportunity. The significant growth in both earnings and dividends per share over recent years also adds to its appeal.

Why You Might Be Interested In WSFS Financial Corporation (NASDAQ:WSFS) For Its Upcoming Dividend

Moomoo AI

Oct 11, 2023 06:53

The recent insider selling at WSFS Financial could be a matter of concern for investors. Despite some alignment between management and smaller investors, no recent insider transactions could be unsettling.

WSFS Financial Insiders Sell US$633k Of Stock, Possibly Signalling Caution

Analysts Notebook

Jun 26, 2023 07:11

Columns US Top Rating Updates on 6/26: MRNA, GOOG, TSLA, TXRH and More

$Cheesecake Factory(CAKE.US)$ initiated at equal-weight by Wells Fargo, announced target price at $33.00.
$Texas Roadhouse(TXRH.US)$ initiated at equal-weight by Wells Fargo, announced targe price at $113.00.
$Moderna(MRNA.US)$ was upgraded by UBS from neutral to buy, but decreased target price from $221.00 to $191.00.
$Sotera Health Company(SHC.US)$ was upgraded by Keybanc from neutral to buy, announced target price at $24.00.
$Alphabet-C(GOOG.US)$ was downg...

Analysts Notebook

Apr 25, 2022 06:06

Columns Top upgrades and downgrades on 4/25

Upgrades
• $Advanced Micro Devices(AMD.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $160
• $AutoNation(AN.US)$ : Truist Securities Upgrades to Buy from Hold - PT $140 (from $130)
• $BioLife Solutions(BLFS.US)$ : Oppenheimer Upgrades to Outperform from Perform - PT $28
• $Biomarin Pharmaceutical(BMRN.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $113 (from $96)
• $GoDaddy(GDDY.US)$ : Piper Sandler Upgrades to Overweight ...

No comment yet